Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)

Agios Pharmaceuticals (AGIO) has 4 years of Capital Leases data on file, last reported at $276000.0 in Q1 2022.

• Quarterly Capital Leases rose 11.29% year-over-year to $276000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $276000.0 (up 11.29% YoY) and the FY2021 annual result came in at $276000.0, down 16.62% from the prior year.
• Capital Leases was little changed at $276000.0 in Q1 2022, from $276000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $673000.0 in Q4 2019 to a low of $167000.0 in Q2 2021.
• A 4-year average of $340428.6 and a median of $276000.0 in 2021 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2020 — Capital Leases tumbled 50.82% — and 2022, when it gained 11.29%.
• Tracing AGIO's Capital Leases over 4 years: stood at $673000.0 in 2019, then plunged by 50.82% to $331000.0 in 2020, then declined by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
• The last three Capital Leases figures came in at $276000.0 (Q1 2022), $276000.0 (Q4 2021), and $167000.0 (Q2 2021), per Business Quant data.